US Stock MarketDetailed Quotes

DRMA Dermata Therapeutics

Watchlist

1.2181
-0.0069-0.56%

Close Nov 4 16:00 ET

1.2000
-0.0181-1.49%

Post 16:21 ET

1.84MMarket Cap-65P/E (TTM)

Dermata Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Assets

Current assets

Cash, cash equivalents and short term investments

-41.37%4.95M

-46.00%4.73M

19.18%7.44M

-17.79%6.63M

-20.60%8.44M

7.03%8.77M

-42.20%6.24M

-35.99%8.07M

-Cash and cash equivalents

-41.37%4.95M

-46.00%4.73M

19.18%7.44M

-17.79%6.63M

-20.60%8.44M

7.03%8.77M

-42.20%6.24M

-35.99%8.07M

Receivables

----

-33.69%8.36K

-99.41%76

--790

--6.36K

--12.6K

--12.89K

-Accrued interest receivable

----

-33.69%8.36K

-99.41%76

--790

--6.36K

--12.6K

--12.89K

Prepaid assets

-47.80%111.16K

-21.13%347.92K

-23.76%517.65K

-22.85%662.58K

-37.94%212.93K

-25.79%441.12K

-11.75%678.99K

-20.66%858.76K

Current deferred assets

--116.76K

----

--0

Other current assets

1.50%61.54K

21.38%98.16K

24.94%14.5K

-19.67%29.25K

9.36%60.63K

2.28%80.87K

--11.6K

--36.41K

Total current assets

-39.90%5.24M

-44.27%5.18M

14.89%7.98M

-18.40%7.32M

-20.98%8.71M

2.78%9.3M

-40.26%6.94M

-34.42%8.97M

Non current assets

Total non current assets

--0

Total assets

-39.90%5.24M

-44.27%5.18M

14.89%7.98M

-18.40%7.32M

-20.98%8.71M

2.78%9.3M

-40.26%6.94M

-34.42%8.97M

Liabilities

Current liabilities

Payables

203.16%1.33M

66.89%822.55K

74.36%866.03K

-1.92%474.46K

-28.09%437.78K

-25.57%492.87K

-3.60%496.7K

-37.17%483.74K

-accounts payable

203.16%1.33M

66.89%822.55K

74.36%866.03K

-1.92%474.46K

-28.09%437.78K

-25.57%492.87K

-3.60%496.7K

-37.17%483.74K

Current accrued expenses

396.35%313.28K

-45.38%318.41K

-83.92%41.1K

-82.51%113.31K

-86.28%63.12K

83.09%582.91K

8.56%255.54K

80,883.38%647.87K

Current liabilities

180.94%1.92M

13.65%1.37M

75.98%1.62M

-39.05%916.82K

-50.03%682.86K

1.30%1.21M

-39.17%922.63K

25.86%1.5M

Non current liabilities

Total non current liabilities

--0

Total liabilities

180.94%1.92M

13.65%1.37M

75.98%1.62M

-39.05%916.82K

-50.03%682.86K

1.30%1.21M

-39.17%922.63K

25.86%1.5M

Shareholders'equity

Share capital

-78.37%69

178.66%666

410.39%393

-73.64%319

-68.42%319

-71.31%239

-90.76%77

45.26%1.21K

-common stock

-78.37%69

178.66%666

410.39%393

-73.64%319

-68.42%319

-71.31%239

-90.76%77

45.26%1.21K

Retained earnings

-19.82%-59.35M

-18.16%-56.52M

-17.10%-53.39M

-16.69%-51.25M

-19.36%-49.53M

-23.38%-47.83M

-26.71%-45.59M

-31.39%-43.92M

Paid-in capital

8.87%62.67M

7.88%60.33M

15.75%59.74M

12.19%57.66M

12.52%57.56M

19.95%55.92M

11.99%51.61M

11.92%51.39M

Total stockholders'equity

-58.68%3.32M

-52.92%3.81M

5.53%6.36M

-14.24%6.41M

-16.87%8.03M

3.00%8.09M

-40.42%6.02M

-83.73%7.47M

Total equity

-58.68%3.32M

-52.92%3.81M

5.53%6.36M

-14.24%6.41M

-16.87%8.03M

3.00%8.09M

-40.42%6.02M

-40.19%7.47M

Currency Unit

USD

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments	-41.37%4.95M	-46.00%4.73M	19.18%7.44M	19.18%7.44M	-17.79%6.63M	-20.60%8.44M	7.03%8.77M	-42.20%6.24M	-42.20%6.24M	-35.99%8.07M
-Cash and cash equivalents	-41.37%4.95M	-46.00%4.73M	19.18%7.44M	19.18%7.44M	-17.79%6.63M	-20.60%8.44M	7.03%8.77M	-42.20%6.24M	-42.20%6.24M	-35.99%8.07M
Receivables	----	----	-33.69%8.36K	-33.69%8.36K	-99.41%76	--790	--6.36K	--12.6K	--12.6K	--12.89K
-Accrued interest receivable	----	----	-33.69%8.36K	-33.69%8.36K	-99.41%76	--790	--6.36K	--12.6K	--12.6K	--12.89K
Prepaid assets	-47.80%111.16K	-21.13%347.92K	-23.76%517.65K	-23.76%517.65K	-22.85%662.58K	-37.94%212.93K	-25.79%441.12K	-11.75%678.99K	-11.75%678.99K	-20.66%858.76K
Current deferred assets	--116.76K	----	----	----	----	----	----	----	----	--0
Other current assets	1.50%61.54K	21.38%98.16K	24.94%14.5K	24.94%14.5K	-19.67%29.25K	9.36%60.63K	2.28%80.87K	--11.6K	--11.6K	--36.41K
Total current assets	-39.90%5.24M	-44.27%5.18M	14.89%7.98M	14.89%7.98M	-18.40%7.32M	-20.98%8.71M	2.78%9.3M	-40.26%6.94M	-40.26%6.94M	-34.42%8.97M
Non current assets
Total non current assets	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Total assets	-39.90%5.24M	-44.27%5.18M	14.89%7.98M	14.89%7.98M	-18.40%7.32M	-20.98%8.71M	2.78%9.3M	-40.26%6.94M	-40.26%6.94M	-34.42%8.97M
Liabilities
Current liabilities
Payables	203.16%1.33M	66.89%822.55K	74.36%866.03K	74.36%866.03K	-1.92%474.46K	-28.09%437.78K	-25.57%492.87K	-3.60%496.7K	-3.60%496.7K	-37.17%483.74K
-accounts payable	203.16%1.33M	66.89%822.55K	74.36%866.03K	74.36%866.03K	-1.92%474.46K	-28.09%437.78K	-25.57%492.87K	-3.60%496.7K	-3.60%496.7K	-37.17%483.74K
Current accrued expenses	396.35%313.28K	-45.38%318.41K	-83.92%41.1K	-83.92%41.1K	-82.51%113.31K	-86.28%63.12K	83.09%582.91K	8.56%255.54K	8.56%255.54K	80,883.38%647.87K
Current liabilities	180.94%1.92M	13.65%1.37M	75.98%1.62M	75.98%1.62M	-39.05%916.82K	-50.03%682.86K	1.30%1.21M	-39.17%922.63K	-39.17%922.63K	25.86%1.5M
Non current liabilities
Total non current liabilities	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Total liabilities	180.94%1.92M	13.65%1.37M	75.98%1.62M	75.98%1.62M	-39.05%916.82K	-50.03%682.86K	1.30%1.21M	-39.17%922.63K	-39.17%922.63K	25.86%1.5M
Shareholders'equity
Share capital	-78.37%69	178.66%666	410.39%393	410.39%393	-73.64%319	-68.42%319	-71.31%239	-90.76%77	-90.76%77	45.26%1.21K
-common stock	-78.37%69	178.66%666	410.39%393	410.39%393	-73.64%319	-68.42%319	-71.31%239	-90.76%77	-90.76%77	45.26%1.21K
Retained earnings	-19.82%-59.35M	-18.16%-56.52M	-17.10%-53.39M	-17.10%-53.39M	-16.69%-51.25M	-19.36%-49.53M	-23.38%-47.83M	-26.71%-45.59M	-26.71%-45.59M	-31.39%-43.92M
Paid-in capital	8.87%62.67M	7.88%60.33M	15.75%59.74M	15.75%59.74M	12.19%57.66M	12.52%57.56M	19.95%55.92M	11.99%51.61M	11.99%51.61M	11.92%51.39M
Total stockholders'equity	-58.68%3.32M	-52.92%3.81M	5.53%6.36M	5.53%6.36M	-14.24%6.41M	-16.87%8.03M	3.00%8.09M	-40.42%6.02M	-40.42%6.02M	-83.73%7.47M
Total equity	-58.68%3.32M	-52.92%3.81M	5.53%6.36M	5.53%6.36M	-14.24%6.41M	-16.87%8.03M	3.00%8.09M	-40.42%6.02M	-40.42%6.02M	-40.19%7.47M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data